Skip to main content
NewslettersWatchlist

23Andme Holding Co.(ME-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low4.64
Day High4.94
Open:4.71
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
the globe and mail
the globe and mail

23andMe settles data breach lawsuit for $30 million

The lawsuit accused the genetics testing company of failing to protect the privacy of 6.9 million customers whose personal information was exposed in a data breach last year
GlobeNewswire
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
GlobeNewswire
23andMe to Report Q2 FY2025 Financial Results
GlobeNewswire
23andMe Regains Compliance With Nasdaq Listing Requirements
GlobeNewswire
23andMe Appoints Three New Independent Directors to Board
Motley Fool
ASML's Latest Chapter in the Semiconductor Story
GlobeNewswire
23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South
Motley Fool
Author Alok Sama on OpenAI, Bubbles, and When to Sell
GlobeNewswire
23andMe Announces Completion of 1-for-20 Reverse Stock Split
GlobeNewswire
23andMe Announces 1-for-20 Reverse Stock Split
GlobeNewswire
23andMe Announces Mathew Knowles as New Brand Ambassador
Reuters
23andMe settles data breach lawsuit for $30 million
Motley Fool
3 Ultra-High-Yield Dividend Stocks to Buy Hand Over Fist Right This Instant
Motley Fool
Why 23andMe Stock Tumbled 10% on Tuesday
Motley Fool
This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next
Motley Fool
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
Motley Fool
A Few Years From Now, You'll Probably Wish You'd Followed Billionaire Investors Into This Stock
Motley Fool
Is 23andMe Stock a Smart Buy Right Now?
Motley Fool
The 3 Worst Stock Investments I Ever Made -- and What I Learned From Them
Newsfile
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation Of 23andMe Holding Co (ME) Data Breach
BayStreet.ca
Why Pancreatic Cancer is No Longer a Death Sentence: Emerging Therapies to Watch
Motley Fool
Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe
Motley Fool
Why 23andMe Holding Stock Plummeted by 13% Today

Profile

23andMe Inc. is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc., formerly known as VG Acquisition Corp., is headquartered in Sunnyvale, CA.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.